Vicarious Surgical (NYSE:RBOT) Shares Down 6% – Here’s Why

Vicarious Surgical Inc. (NYSE:RBOT)’s stock price traded down 6% on Friday . The stock traded as low as $0.45 and last traded at $0.47. 21,341 shares traded hands during trading, a decline of 76% from the average session volume of 87,648 shares. The stock had previously closed at $0.50.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Vicarious Surgical in a report on Wednesday, January 21st. Wall Street Zen cut Vicarious Surgical from a “hold” rating to a “sell” rating in a report on Saturday, March 7th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average target price of $7.00.

Vicarious Surgical Price Performance

The company has a market capitalization of $3.35 million, a P/E ratio of -0.05 and a beta of 1.50. The company has a fifty day moving average price of $0.95 and a two-hundred day moving average price of $2.36.

Vicarious Surgical (NYSE:RBOT) last announced its earnings results on Monday, March 9th. The company reported ($1.65) EPS for the quarter, missing the consensus estimate of ($1.37) by ($0.28). As a group, sell-side analysts forecast that Vicarious Surgical Inc. will post -10.89 earnings per share for the current year.

Institutional Trading of Vicarious Surgical

Institutional investors have recently added to or reduced their stakes in the stock. XTX Topco Ltd bought a new stake in Vicarious Surgical in the fourth quarter valued at approximately $27,000. Dimensional Fund Advisors LP boosted its holdings in Vicarious Surgical by 22.1% in the third quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after acquiring an additional 3,615 shares during the last quarter. Connective Capital Management LLC bought a new stake in Vicarious Surgical in the third quarter valued at approximately $169,000. Geode Capital Management LLC boosted its holdings in Vicarious Surgical by 26.0% in the fourth quarter. Geode Capital Management LLC now owns 40,494 shares of the company’s stock valued at $88,000 after acquiring an additional 8,344 shares during the last quarter. Finally, Jane Street Group LLC bought a new stake in Vicarious Surgical in the fourth quarter valued at approximately $98,000. 47.27% of the stock is currently owned by institutional investors.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.